Results 161 to 170 of about 10,167,326 (383)

Determination of ADP/ATP translocase isoform ratios in malignancy and cellular senescence

open access: yesMolecular Oncology, EarlyView.
The individual functions of three isoforms exchanging ADP and ATP (ADP/ATP translocases; ANTs) on the mitochondrial membrane remain unclear. We developed a method for quantitatively differentiating highly similar human ANT1, ANT2, and ANT3 using parallel reaction monitoring. This method allowed us to assess changes in translocase levels during cellular
Zuzana Liblova   +18 more
wiley   +1 more source

Chronic Endometritis and Chronic Metritis in Virgins.* [PDF]

open access: yesBJOG: An International Journal of Obstetrics & Gynaecology, 1904
n ...
openaire   +2 more sources

Evaluation of US Food and Drug Administration-recommended abuse-potential questions in chronic pain patients without history of recreational opioid use: results and plan for research

open access: yesJournal of Pain Research, 2018
Joseph A Boscarino,1 Carrie A Withey,1 Ryan J Dugan,1 Thomas Alfieri2 1Department of Epidemiology and Health Services Research, Geisinger Clinic, Danville, PA 17822, USA; 2Medical Affairs, Purdue Pharma, Stamford, CT 06901, USA Background: Existing ...
Boscarino JA   +3 more
doaj  

Early metastasis is characterized by Gr1+ cell dysregulation and is inhibited by immunomodulatory nanoparticles

open access: yesMolecular Oncology, EarlyView.
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma   +9 more
wiley   +1 more source

Potential Savings Through Prevention of Avoidable Chronic Illness Among CalPERS State Active Members [PDF]

open access: yes, 2012
Analyzes chronic disease-related health expenditures among state employees that can be targeted by lifestyle interventions.
Barbara A. Ormond   +2 more
core  

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

open access: yesMolecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy